Evidence map›Paper›PMID 35416035›Full record

ArticleACS sensors2022

Molecularly Imprinted Polymer Nanoparticles Enable Rapid, Reliable, and Robust Point-of-Care Thermal Detection of SARS-CoV-2.

Jake McClements, Laure Bar, Pankaj Singla, Francesco Canfarotta, Alan Thomson, Joanna Czulak, Rhiannon E Johnson, Robert D Crapnell, Craig E Banks, Brendan Payne and 3 more

Open access · hybridAbstract read
In one paragraph

Article in ACS sensors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
8.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 87 citations in OpenAlex.

  1. Review
  2. Review
  3. [Molecular imprinting strategies and advances targeting biomembranes].Se pu = Chinese journal of chromatography · 2026
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Double Imprinted Nanoparticles for Sequential Membrane-to-Nuclear Drug Delivery.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Jake McClementsSchool of Engineering, Newcastle University, Merz Court, Claremont Road, Newcastle upon Tyne NE1 7RU, United Kingdom.
Laure BarExperimental Soft Matter and Thermal Physics (EST) Group, Department of Physics, Université Libré de Bruxelles, Boulevard du Triomphe CP223, Brussels 1050, Belgium.
Pankaj SinglaSchool of Engineering, Newcastle University, Merz Court, Claremont Road, Newcastle upon Tyne NE1 7RU, United Kingdom.
Francesco CanfarottaMIP Diagnostics Ltd., The Exchange Building, Colworth Park, Sharnbrook, Bedford MK44 1LQ, United Kingdom.
Alan ThomsonMIP Diagnostics Ltd., The Exchange Building, Colworth Park, Sharnbrook, Bedford MK44 1LQ, United Kingdom.
Joanna CzulakMIP Diagnostics Ltd., The Exchange Building, Colworth Park, Sharnbrook, Bedford MK44 1LQ, United Kingdom.ORCID 0000-0003-0100-8541
Rhiannon E JohnsonMIP Diagnostics Ltd., The Exchange Building, Colworth Park, Sharnbrook, Bedford MK44 1LQ, United Kingdom.ORCID 0000-0002-2587-2564
Robert D CrapnellFaculty of Science and Engineering, Manchester Metropolitan University, John Dalton Building, Chester Street, Manchester M1 5GD, United Kingdom.
Craig E BanksFaculty of Science and Engineering, Manchester Metropolitan University, John Dalton Building, Chester Street, Manchester M1 5GD, United Kingdom.ORCID 0000-0002-0756-9764
Brendan PayneDepartment of Infection and Tropical Medicine, Royal Victoria Infirmary, Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne NE1 4LP, United Kingdom.
Shayan SeyedinSchool of Engineering, Newcastle University, Merz Court, Claremont Road, Newcastle upon Tyne NE1 7RU, United Kingdom.ORCID 0000-0001-7322-0387
Patricia Losada-PérezExperimental Soft Matter and Thermal Physics (EST) Group, Department of Physics, Université Libré de Bruxelles, Boulevard du Triomphe CP223, Brussels 1050, Belgium.
Marloes PeetersSchool of Engineering, Newcastle University, Merz Court, Claremont Road, Newcastle upon Tyne NE1 7RU, United Kingdom.ORCID 0000-0002-0429-8073
Newcastle University · GBManchester Metropolitan University · GBUniversité Libre de Bruxelles · BERoyal Victoria Infirmary · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rapid antigen tests are currently used for population screening of COVID-19. However, they lack sensitivity and utilize antibodies as receptors, which can only function in narrow temperature and pH ranges. Consequently, molecularly imprinted polymer nanoparticles (nanoMIPs) are synthetized with a fast (2 h) and scalable process using merely a tiny SARS-CoV-2 fragment (∼10 amino acids). The nanoMIPs rival the affinity of SARS-CoV-2 antibodies under standard testing conditions and surpass them at elevated temperatures or in acidic media. Therefore, nanoMIP sensors possess clear advantages over antibody-based assays as they can function in various challenging media. A thermal assay is developed with nanoMIPs electrografted onto screen-printed electrodes to accurately quantify SARS-CoV-2 antigens. Heat transfer-based measurements demonstrate superior detection limits compared to commercial rapid antigen tests and most antigen tests from the literature for both the alpha (∼9.9 fg mL

Indexed as

COVID-19Molecular ImprintingNanoparticlesAntibodiesHumansMolecularly Imprinted PolymersPoint-of-Care SystemsSARS-CoV-2AntibodiesMolecularly Imprinted PolymersbiosensorsCOVID-19diagnostic testingheat transfer method (HTM)molecularly imprinted polymer nanoparticles (nanoMIPs)point-of-care testingSARS-CoV-2

Identifiers

PMID35416035
PMCPMC9016778
OpenAlexW4223573456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.